Erlotinib (tarceva) - Cancer Science

Relevant Publications

Combination of microwave ablation and systemic treatments achieve a long survival time for a patient with metachronous advanced double primary lung and colon adenocarcinoma: A case report.

Issue Release: 2024

Perifollicular Xanthoma Occurring in Patients after Erlotinib Treatment.

Issue Release: 2022

Presumed erlotinib-induced bilateral corneal ulcers in a dog with lung tumor.

Issue Release: 2022

Downregulation of p38 MAPK Activation and Radiation-Sensitive 52 Expression Enhances 5-Fluorouracil and Erlotinib-Induced Cytotoxicity in Human Lung Squamous Cells.

Issue Release: 2021

Capsanthin induces G1/S phase arrest, erlotinib-sensitivity and inhibits tumor progression by suppressing EZH2-mediated epigenetically silencing of p21 in triple-negative breast cancer cells.

Issue Release: 2021

Nitrogen-Containing Heterocycles as Anticancer Agents: An Overview.

Issue Release: 2020

FTIR spectra signatures reveal different cellular effects of EGFR inhibitors on nonsmall cell lung cancer cells.

Issue Release: 2020

MiRNA-7 Replacement Effect on Proliferation and Tarceva-Sensitivity in U373-MG Cell Line.

Issue Release: 2020

The combination of bevacizumab/Avastin and erlotinib/Tarceva is relevant for the treatment of metastatic renal cell carcinoma: the role of a synonymous mutation of the EGFR receptor.

Issue Release: 2020

Epithelial growth factor receptor tyrosine kinase inhibitors alleviate house dust mite allergen Der p2-induced IL-6 and IL-8.

Issue Release: 2019

Capsaicin enhances erlotinib-induced cytotoxicity AKT inactivation and excision repair cross-complementary 1 (ERCC1) down-regulation in human lung cancer cells.

Issue Release: 2019

The Use of Extract in Treating Erlotinib (Tarceva®) Associated Rash: A Case Report.

Issue Release: 2019

Epidermal growth factor receptor paracrine upregulation in idiopathic pulmonary fibrosis fibroblasts is blocked by nintedanib.

Issue Release: 2019

Pharmacokinetics and safety of erlotinib and its metabolite OSI-420 in infants and children with primary brain tumors.

Issue Release: 2019

Erlotinib.

Issue Release: 2019

Synthesis of Novel Thieno[2,3-d]pyrimidine Derivatives and Evaluation of Their Cytotoxicity and EGFR Inhibitory Activity.

Issue Release: 2018

Effects and mechanisms of betulinic acid on improving EGFR TKI-resistance of lung cancer cells.

Issue Release: 2018

Phase I Trial Using Induction Ciplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib With Concurrent Radiotherapy for Advanced Head and Neck Cancer.

Issue Release: 2018

Astaxanthin enhances erlotinib-induced cytotoxicity by p38 MAPK mediated xeroderma pigmentosum complementation group C (XPC) down-regulation in human lung cancer cells.

Issue Release: 2018

Medication related osteonecrosis of the jaws associated with targeted therapy as monotherapy and in combination with antiresorptives. A report of 7 cases from the Copenhagen Cohort.

Issue Release: 2017

What role do biomarkers play in cancer treatment?

How Do Blister Packs Benefit Cancer Patients?

How to Prepare for Bone Marrow Aspiration?

What are the Benefits of Telemedicine in Cancer Care?

Which Types of Cancer Are Most Commonly Associated with Dysphagia?

How do Keratins Affect Tumor Behavior?

Which Cancers are Associated with MSI-H?

What are the Challenges in Using Natural Compounds for Cancer Treatment?

How is Processed Meat Linked to Cancer?

Why is Tumor Location Important in Cancer?

Partnered Content Networks

Relevant Topics